Skip to content

From symptoms to a protocol, in five days.

Pick a panel or take the quiz, draw blood at a Quest lab or at home, and read clear results alongside the peer-reviewed research on what's optimal for women.

01 — The flow

Four steps, nothing hidden.

  1. 01

    Match your panel

    3-minute quiz · $149 per panel

    Pick one of 10 flat-priced panels at $149, or take our 3-minute symptom quiz and we'll build a custom panel from the 180+ biomarker library, priced à la carte.

  2. 02

    Draw blood — your way

    50 U.S. states · Quest Diagnostics

    Book a draw at any of 2,250+ Quest Diagnostics patient service centers nationwide, or have a certified phlebotomist come to your home or office.

  3. 03

    Most results in 5 days

    ~5-day turnaround for most tests · CLIA-accredited

    Every biomarker lands in your private portal with the standard lab range, the research-backed optimal, and a plain-language note on what it means for a woman at your life stage. A handful of specialty markers can take up to 21 days; we flag the timeline at checkout.

  4. 04

    Re-test and track

    Longitudinal trends · Same-panel re-tests

    Re-test the same panel whenever you want. Every biomarker is charted over time in your portal so you can watch it move as your protocol takes hold — or as perimenopause, pregnancy, or training load shifts your baseline.

02 — Where you draw

Quest lab, or your kitchen table.

Every sample is processed by Quest Diagnostics — CLIA/CAP-accredited and the largest clinical lab network in the U.S. Pick the draw that actually fits your week.

2,250+U.S. locations

At a Quest patient service center

  • Walk in during business hours at any Quest location
  • Average 15-minute visit; results start processing same day
  • Covered in your flat $149 panel price
200+ZIP codes

At home, at the office, or on the road

  • Certified phlebotomist travels to you
  • Early-morning and weekend slots for fasting draws
  • Add $75 in select ZIPs; check availability at checkout
03 — Your results

Not “in range.” In context.

Every biomarker arrives with the standard CLIA lab range, the research-backed optimal for women, and a short note on what the number actually means at your life stage — cycle phase, perimenopause, postpartum, or cycling normally.

Every claim is cited. You can read the underlying paper, share the report with your own clinician, or ask us to.

Sample reportHormones & Longevity
  • Estradiol74 pg/mL
    In range
  • TSH3.8 mIU/L
    Borderline — research target < 2.5
  • Ferritin22 ng/mL
    Low — common driver of fatigue in women
  • Vitamin D56 nmol/L
    In range
04 — The questions we get most

Quick answers, no fine print.

No. EllaDx is direct-to-consumer; a licensed physician orders and reviews every panel. Panels are HSA- and FSA-eligible.
No. Every panel is a standard venous draw — the same sample type your primary care doctor uses — processed by Quest Diagnostics.
No — EllaDx does not provide physician review of individual results. Your report includes plain-language explanations and research-backed context designed for women, but it is not medical advice. For interpretation and treatment decisions, share your report with your own healthcare provider.
Every 3–6 months for most markers; sooner if you're actively adjusting a protocol. You can re-run the same panel whenever you need to — longitudinal charts comparing every test you've taken are included in your portal.
Yes — we're live in all 50 U.S. states. Venous draws happen at any of 2,250+ Quest patient service centers; at-home draws are available in select ZIP codes.
  • CLIA & CAP-accredited U.S. labs
  • HSA & FSA eligible
  • No insurance required

Medical disclaimer. EllaDx provides laboratory testing and educational information only. It is not medical advice, diagnosis, or treatment, and does not replace consultation with your healthcare provider. If you are experiencing a medical emergency, call 911.

Get started

Take 10 minutes. Understand yourself for years.

Take the 3-min quiz

Founded in Dallas, Texas · 2024